Dr. Strosberg discusses the safety profile and long-term toxicities of 212Pb-DOTAMTATE treatment, highlighting renal issues and achalasia in patients.
Jonathan Strosberg, MD
Articles by Jonathan Strosberg, MD
Dr. Jonathan Strosberg discusses the promising results of the ALPHAMEDIX-02 trial, evaluating a new therapy for advanced neuroendocrine tumors.
A real-world guide to best practices in treating neuroendocrine tumors can improve patient outcomes.